VIVUS Press Releases

Date Title Links
Toggle Summary VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date
CAMPBELL, Calif. , Nov. 13, 2020 (GLOBE NEWSWIRE) -- On November 10, 2020 , VIVUS, Inc. (the “ Company ”), a biopharmaceutical company, filed the Second Amended   Joint Prepackaged Chapter 11 Plan of Reorganization of VIVUS, Inc. and Its Affiliated Debtors [Docket No. 339] (as may be amended,
View HTML
Toggle Summary VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC
CAMPBELL, Calif. , July 07, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has completed the solicitation of an in-court prepackaged plan of reorganization, under which IEH Biopharma LLC (“ IEH ”) will take 100% ownership of
View HTML
Toggle Summary VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.
CAMPBELL, Calif. , June 02, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has updated its agreement regarding its corporate debt with Icahn Enterprises Holdings L.P. (dba IEH Biopharma LLC ), which holds a principal amount
View HTML
Toggle Summary VIVUS Reports First Quarter 2020 Financial Results
Company to host conference call today at 4:30pm ET CAMPBELL, Calif. , May 06, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today reported financial results for the quarter ended March 31, 2020 and provided a business update.
View HTML
Toggle Summary VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020
CAMPBELL, Calif. , May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the first quarter of 2020 after the market close on Wednesday, May 6, 2020 . The Company will host a conference call beginning at
View HTML
Toggle Summary VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt
CAMPBELL, Calif. , May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced an agreement regarding its corporate debt with IEH Biopharma LLC , which holds a principal amount of  approximately $170.1 million of the Company’s Convertible
View HTML
Toggle Summary VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
CAMPBELL, Calif. , April 03, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced the completion of its previously announced registered direct offering of 7,218,750 shares of the Company’s common stock at a purchase price of $1.60 per
View HTML
Toggle Summary VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
CAMPBELL, Calif. , April 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 7,218,750 shares of the
View HTML
Toggle Summary VIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing”
Virtual office visits and smart health devices available through the VIVUS Health Platform give physicians new tools for optimizing patient care and protecting the health of those at increased risk for COVID-19 CAMPBELL, Calif. , March 31, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc.
View HTML
Toggle Summary VIVUS Reports Fourth Quarter and Full Year 2019 Financial Results
- Company to host conference call today at 4:30pm ET - CAMPBELL, Calif. , March 03, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today reported financial results for the quarter and fiscal year ended December 31, 2019 and provided a business
View HTML